Patent News News 15 October 2025

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson has struck a $3.05 billion cash deal to acquire Halda Therapeutics, a privately held cancer-drug developer based in New Haven, Connecticut, in one of 2025’s biggest oncology takeovers so far. Reuters+1 The move deepens J&J’s bet on

17 November 2025

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

In summary, Gilead’s share price has rallied on a wave of HIV-related breakthroughs, pipeline achievements, and upbeat guidance. With third-quarter results due Oct. 30, investors will be watching for sustained growth. For now, analysts remain generally optimistic: the consensus rating

18 October 2025

HIV Treatment · Investment Strategies · Patent News · Pharmaceutical Industry · Stocks

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Stock Jumps as Outlook Brightens Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share benzinga.com. Year-to-date, the stock has

17 October 2025

Analyst Ratings · Biotechnology · HIV Research · Patent News · Stock Market

Dragonfly Energy (DFLI) Patent News Sends Stock Soaring – Will the Rally Last?

Dragonfly Energy Holdings (DFLI) – US-listed maker of Battle Born® lithium batteries – saw its stock surge on Oct. 15, 2025. The company’s new patent for wireless battery communication and a solid Q3 sales beat have energized investors. (Image: Dragonfly

15 October 2025

Investment Insights · Patent News · Renewable Energy · Stock Market · Technology Trends

Patent News News 15 October 2025 - 17 November 2025

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Dragonfly Energy (DFLI) Patent News Sends Stock Soaring – Will the Rally Last?